Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
of the power converters in collaboration with our industry partners. The candidate will have the opportunity to work with state-of-the-art tools for simulation and design power converter and advanced power
-
, suitable for wearable or implantable devices. The research will focus on hardware-software co-design, from modeling spiking behavior to implementing scalable architectures on silicon. Key research themes
-
range of advanced functional genomics methods, particularly single-cell technologies, in pre-clinical model systems such as cell lines and patient-derived tumor organoids as well as patient samples
-
sciences and advancing vaccine development. NIVI-R conducts scientific research, while NIVI-D works to quickly turn that research into new vaccine candidates. NIVI-D accelerates clinical trials (phases 1 and
-
with the aim of making it a practical computational tool in the near term. The project will focus on Gaussian Boson Sampling (GBS), which is a specialized photonic quantum computing model with
-
partners. The candidate will have the opportunity to work with state-of-the-art tools for simulation and design power converter and electric machine and control the converter with advanced power electronic
-
of cyber security and hybrid threats in a changing world order, including relevant theoretical skills. The ability to formulate independent and original research questions and designs, including advanced
-
on recent advances in Higher-Order Mathematical Operational Semantics, a pivotal generalization of Turi and Plotkin's seminal approach to structural operational semantics. We seek an apt and motivated PhD
-
on the homepage, www.healthtech.dtu.dk/research/research-sections/section-idun ) at DTU Health Tech. In the group, we are exploring and developing targeted and advanced delivery systems to be able
-
/Cas and degron systems) with a range of advanced functional genomics methods, particularly single-cell technologies, in pre-clinical model systems such as cell lines and patient-derived tumor organoids